A critical breakthrough in cancer investigation is emerging with the use of VHH fragments to restore mutated p53. This crucial malignant inhibitor protein is frequently disabled in many types of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research